ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 55 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $205,000 | -20.5% | 197,855 | -43.0% | 0.00% | – |
| Q4 2018 | $258,000 | -4.4% | 347,126 | +172.3% | 0.00% | – |
| Q3 2018 | $270,000 | -0.4% | 127,480 | +8.7% | 0.00% | – |
| Q2 2018 | $271,000 | -27.3% | 117,330 | 0.0% | 0.00% | – |
| Q1 2018 | $373,000 | -22.5% | 117,330 | 0.0% | 0.00% | – |
| Q4 2017 | $481,000 | -14.6% | 117,330 | -5.8% | 0.00% | – |
| Q3 2017 | $563,000 | +36.0% | 124,569 | 0.0% | 0.00% | – |
| Q2 2017 | $414,000 | -72.7% | 124,569 | -24.5% | 0.00% | -100.0% |
| Q1 2017 | $1,518,000 | +18.8% | 164,888 | -0.6% | 0.00% | 0.0% |
| Q4 2016 | $1,278,000 | -19.3% | 165,963 | +19.8% | 0.00% | 0.0% |
| Q3 2016 | $1,583,000 | +20.3% | 138,506 | +29.5% | 0.00% | 0.0% |
| Q2 2016 | $1,316,000 | +27.5% | 106,982 | +4.8% | 0.00% | 0.0% |
| Q1 2016 | $1,032,000 | -55.2% | 102,089 | -0.1% | 0.00% | 0.0% |
| Q4 2015 | $2,302,000 | +52.0% | 102,162 | +11.9% | 0.00% | 0.0% |
| Q3 2015 | $1,514,000 | -28.6% | 91,317 | -3.1% | 0.00% | 0.0% |
| Q2 2015 | $2,119,000 | +15.5% | 94,190 | +32.3% | 0.00% | 0.0% |
| Q1 2015 | $1,834,000 | +22.1% | 71,174 | +3.1% | 0.00% | 0.0% |
| Q4 2014 | $1,502,000 | +29.9% | 69,027 | +13.0% | 0.00% | 0.0% |
| Q3 2014 | $1,156,000 | +35.4% | 61,112 | +66.6% | 0.00% | 0.0% |
| Q2 2014 | $854,000 | -17.9% | 36,681 | +18.6% | 0.00% | 0.0% |
| Q1 2014 | $1,040,000 | +19.4% | 30,921 | +4.7% | 0.00% | 0.0% |
| Q4 2013 | $871,000 | +105.9% | 29,522 | +6.8% | 0.00% | – |
| Q3 2013 | $423,000 | – | 27,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |